A nurse is admitting a patient with a subarachnoid hemorrhage and expects to administer which of the following medications to decrease intracranial pressure (ICP)?
Nicardipine
Dopamine
Mannitol
Phenytoin .
The Correct Answer is C
Choice A rationale
Nicardipine is a calcium channel blocker used to treat high blood pressure. While it can be used in the management of subarachnoid hemorrhage, it is not primarily used to decrease intracranial pressure.
Choice B rationale
Dopamine is a type of medication used to treat certain conditions such as low blood pressure, heart failure, and Parkinson’s disease. It is not typically used to decrease intracranial pressure in the context of a subarachnoid hemorrhage.
Choice C rationale
Mannitol is a type of medication that is used to decrease intracranial pressure. It works by drawing fluid out of the brain to help reduce swelling.
Choice D rationale
Phenytoin is a medication used to control seizures. While it can be used in the management of subarachnoid hemorrhage, it is not primarily used to decrease intracranial pressure. Migraine Explore
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale
The aura phase is characterized by sensory, motor, or visual disturbances that occur before the headache phase of a migraine. Symptoms such as tingling of the face and blind spots in the eyes are common during this phase.
Choice B rationale
The postdrome phase, also known as the “migraine hangover,” occurs after the headache phase. It does not typically include symptoms such as tingling of the face or blind spots in the eyes.
Choice C rationale
The prodrome phase, also known as the pre-headache phase, can occur hours to days before the headache phase. It can include symptoms such as mood changes, food cravings, and neck stiffness, but not typically tingling of the face or blind spots in the eyes.
Choice D rationale
The headache phase is the period during a migraine when the actual headache occurs. It is not typically associated with symptoms such as tingling of the face or blind spots in the eyes.
Correct Answer is A
Explanation
Choice A rationale
Rebleeding of the injury is a significant factor related to a high mortality rate for a client who has a subarachnoid hemorrhage (SAH). SAH is a devastating event with substantial mortality and high morbidity among survivors. The most common primary causes of death or neurological devastation leading to withdrawal of support are direct effects of the primary hemorrhage (55%) and aneurysm rebleeding (17%)2. Therefore, rebleeding of the injury is a critical concern in the management of SAH.
Choice B rationale
Decreased cerebrospinal fluid is not directly linked to a high mortality rate in SAH. While changes in cerebrospinal fluid dynamics can occur after SAH, it’s not typically a primary factor contributing to mortality.
Choice C rationale
The use of nimodipine is actually part of the treatment protocol for SAH. Nimodipine is a calcium channel blocker that is used to prevent cerebral vasospasm, a complication of SAH. It does not contribute to a higher mortality rate.
Choice D rationale
Poor functional ability could be a result of SAH due to neurological damage, but it is not a direct cause of high mortality. The severity of the initial hemorrhage and subsequent
complications like rebleeding or medical complications are more directly tied to mortality rates.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.